Villarreal-Garcia V, Estupinan-Jimenez JR, Vivas-Mejia PE, Gonzalez-Villasana V, Vazquez-Guillen JM, Resendez-Perez D. A vicious circle in breast cancer: the interplay between inflammation, reactive oxygen species, and microRNAs. Front Oncol. 2022;12:980694.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Nickerson JA, Wu Q, Imbalzano AN. Mammalian SWI/SNF enzymes and the epigenetics of Tumor Cell metabolic reprogramming. Front Oncol. 2017;7:49.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Roberts CW. CARMA: CARM1 methylation of SWI/SNF in breast cancer. Cancer Cell. 2014;25(1):3–4.

Article  PubMed  PubMed Central  Google Scholar 

Sethuraman A, Brown M, Seagroves TN, Wu ZH, Pfeffer LM, Fan M. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway. Breast Cancer Res. 2016;18(1):81.

Article  PubMed  PubMed Central  Google Scholar 

Weissman B, Knudsen KE. Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer. Cancer Res. 2009;69(21):8223–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saha A, Wittmeyer J, Cairns BR. Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Bio. 2006;7(6):437–47.

Article  CAS  Google Scholar 

Luchini C, Veronese N, Solmi M, Cho H, Kim JH, Chou A, et al. Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis. Oncotarget. 2015;6(36):39088–97.

Article  PubMed  PubMed Central  Google Scholar 

Wu JI, Lessard J, Crabtree GR. Understanding the words of chromatin regulation. Cell. 2009;136(2):200–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Michel BC, D’Avino AR, Cassel SH, Mashtalir N, McKenzie ZM, McBride MJ, et al. A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation. Nat Cell Biol. 2018;20(12):1410–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan J, Meyers RM, Michel BC, Mashtalir N, Sizemore AE, Wells JN, et al. Interrogation of mammalian protein complex structure, function, and membership using genome-scale fitness screens. Cell Syst. 2018;6(5):555–68. e7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alpsoy A, Dykhuizen EC. Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexes. J Biol Chem. 2018;293(11):3892–903.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roberts CW, Orkin SH. The SWI/SNF complex–chromatin and cancer. Nat Rev Cancer. 2004;4(2):133–42.

Article  CAS  PubMed  Google Scholar 

Biegel JA, Busse TM, Weissman BE. SWI/SNF chromatin remodeling complexes and cancer. Am J Med Genet C Semin Med Genet. 2014;166 C(3):350–66.

Article  PubMed  Google Scholar 

Feinberg AP. Epigenetic stochasticity, nuclear structure and cancer: the implications for medicine. J Intern Med. 2014;276(1):5–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilson BG, Roberts CW. SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer. 2011;11(7):481–92.

Article  CAS  PubMed  Google Scholar 

Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature. 2011;469(7331):539–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Q, Lian JB, Stein JL, Stein GS, Nickerson JA, Imbalzano AN. The BRG1 ATPase of human SWI/SNF chromatin remodeling enzymes as a driver of cancer. Epigenomics. 2017;9(6):919–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui Y, Bai X, Niu M, Qin Y, Zhang X, Pang D. Upregulated expression of AT-rich interactive domain-containing protein 1B predicts poor prognosis in patients with triple-negative breast cancer. Oncol Lett. 2019;17(3):3289–95.

CAS  PubMed  PubMed Central  Google Scholar 

Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, et al. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet. 2013;45(6):592–601.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu JN, Roberts CW. ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov. 2013;3(1):35–43.

Article  CAS  PubMed  Google Scholar 

Davó-Martínez C, Helfricht A, Ribeiro-Silva C, Raams A, Tresini M, Uruci S, et al. Different SWI/SNF complexes coordinately promote R-loop- and RAD52-dependent transcription-coupled homologous recombination. Nucleic Acids Res. 2023;51(17):9055–74.

Article  PubMed  PubMed Central  Google Scholar 

Jones S, Stransky N, McCord CL, Cerami E, Lagowski J, Kelly D, et al. Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes. Nat Commun. 2014;5:5006.

Article  CAS  PubMed  Google Scholar 

Mao TL, Shih Ie M. The roles of ARID1A in gynecologic cancer. J Gynecol Oncol. 2013;24(4):376–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samartzis EP, Noske A, Dedes KJ, Fink D, Imesch P. ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. Int J Mol Sci. 2013;14(9):18824–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yates LR, Knappskog S, Wedge D, Farmery JHR, Gonzalez S, Martincorena I, et al. Genomic evolution of breast Cancer metastasis and relapse. Cancer Cell. 2017;32(2):169–84. e7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang XW, Zhang YX, Zhao JY, Wu YJ, Zhang N, Shen WJ. ARID1A mutations in cancer development: mechanism and therapy. Carcinogenesis. 2023;44(3):197–208.

Article  CAS  PubMed  Google Scholar 

Schwartz CJ, Pareja F, da Silva EM, Selenica P, Ross DS, Weigelt B, et al. Histologic and genomic features of breast cancers with alterations affecting the SWI/SNF (SMARC) genes. Mod Pathol. 2021;34(10):1850–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun XX, Wang SC, Wei YL, Luo X, Jia YM, Li L, et al. Has context-dependent oncogenic and tumor suppressor functions in Liver Cancer. Cancer Cell. 2017;32(5):574–.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szpon L, Agrawal A, Jelen M, Lipinski A, Rudnicki J, Makuch S, et al. ARID1A/BAF250a is significantly overexpressed in primary invasive breast cancer. Transl Cancer Res. 2020;9(6):3937–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo X, Zhang Y, Mayakonda A, Madan V, Ding LW, Lin LH, et al. ARID1A and CEBPalpha cooperatively inhibit UCA1 transcription in breast cancer. Oncogene. 2018;37(45):5939–51.

Article  CAS  PubMed  Google Scholar 

Xu G, Chhangawala S, Cocco E, Razavi P, Cai Y, Otto JE, et al. ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer. Nat Genet. 2020;52(2):198–207.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suryo Rahmanto Y, Shen W, Shi X, Chen X, Yu Y, Yu ZC, et al. Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming. Nat Commun. 2020;11(1):2717.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allo G, Bernardini MQ, Wu RC, Shih Ie M, Kalloger S, Pollett A, et al. ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas. Mod Pathol. 2014;27(2):255–61.

Article  CAS  PubMed